Buy Rating Affirmed for Syros Pharmaceuticals Amid Promising Clinical Trials and Strategic …

2nd April 2024

Related Stocks. SYRS. 5.04. -0.31 (-5.79%). 4/1/2024. Syros Pharmaceuticals Inc Registered Shs … designs. The anticipation of positive results …